Transcat TRNS 深 沪
交易中 11-03 10:24:18 美东时间
72.65
0.000
0.00%
华盛通- 最 高76.47
- 今 开73.00
- 成交量 1.46万股
- 最 低 71.68
- 昨 收 72.65
- 总市值 6.77亿
- 52周最高 112.94
- 市盈率 静 46.32
- 换手率 0.16%
- 52周最低 67.555
- 委 比 -76.47%
- 总股本 931.77万
- 历史最高 147.115
- 量 比 1.40
- 振 幅 6.59%
- 历史最低 4.97
- 每 手 1
- 风险率 12.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Anteris Receives FDA Approval To Initiate PARADIGM, Global IDE Clinical Trial Designed To Evaluate DurAVR THV In Patients With Severe Calcific Aortic Stenosis And To Support Future PMA Submission
PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devicesMINNEAPOLIS and BRISBANE, Australia,
今天 20:24
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
今天 19:11
An Overview of Transcat's Earnings
Transcat (NASDAQ:TRNS) is gearing up to announce its quarterly earnings on Mond...
11-01 03:02
华尔街顶级分析师最新评级报告：联合健康遭下调
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需重点关注的评级信息。 五大评级上调案例 思佳讯...
10-29 22:12
Autonomix Medical To Present At TCT 2025 Conference Showcasing Initial Results From Its First-in-Human Study On Transvascular Nerve-Targeted Therapy To Reduce Pancreatic Cancer Pain
Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it will be featured in two podium
10-24 21:05
Anteris Technologies Receives Danish Regulatory Clearance To Launch Global PARADIGM Trial For DurAVR Heart Valve
Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR))) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore
10-15 21:21
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
<p>Terns Pharmaceuticals granted equity inducement awards to four new employees as of October 1, 2025, under its 2022 Employment Inducement Award Plan. The awards include options to purchase 118,000 shares of common stock with an exercise price of $7.81 per share, vesting over four years. The options were approved by the Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4) and aim to induce the employees to accept employment w...
10-02 20:05
Transcat Announces New Corporate Controller Appointment
Transcat ( ($TRNS) ) has shared an update. Transcat, Inc. has announced the ret...
09-12 04:59
Transcat CEO to step down; FY26 outlook reaffirmed
Transcat (NASDAQ:TRNS) said Monday that CEO Lee D. Rudow will step down in March 2026 after more than 10 years in the role and will remain as a strategic advisor through 2027. The company has also rea...
08-26 04:21
HC Wainwright & Co. Reiterates Buy on Transcat, Maintains $116 Price Target
HC Wainwright & Co. analyst Scott Buck reiterates Transcat (NASDAQ:TRNS) with a Buy and maintains $116 price target.
08-22 18:04
